BRUSSELS APPROVES NOVARTIS TAKEOVER OF EBEWE
September 1st, 2009
BY KEITH NUTHALL
THE EUROPEAN Commission has granted competition approval to the takeover of Austria's generic pharmaceuticals company EBEWE Spezial-Pharma Holding by Novartis, of Switzerland, enabling the Euro 1.3 billion deal to go ahead. Despite Novartis also making generic medicines, the Commission concluded that the deal "would not significantly impede effective competition" in Europe. EBEWE SP manufactures and sells specialty generic pharmaceutical products (focusing on generic oncology) and undertakes contract manufacturing of finished dose ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.